Dose-dense AC Followed by Paclitaxel/Pertuzumab/Trastuzumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of dose-dense cyclophosphamide and doxorubicin followed by paclitaxel, pertuzumab and trastuzumab that can be used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.

**Synonyms:** - Dose-Dense AC-THP - Dose-dense AC Followed by Paclitaxel-Pertuzumab-Trastuzumab - Dose-dense AC Followed by Paclitaxel-Pertuzumab-Trastuzumab Regimen - Dose-dense AC Followed by Paclitaxel/Pertuzumab/Trastuzumab - Dose-dense AC Followed by Paclitaxel/Trastuzumab/Pertuzumab Regimen - Dose-dense Adriamycin/Cytoxan Followed by Taxol/Herceptin/Perjeta - Dose-dense Doxorubicin/Cyclophosphamide Followed by Paclitaxel/Pertuzumab/Trastuzumab Regimen - ddAC-THP (Paclitaxel) - ddAC-THP (Paclitaxel) (trastuzumab-anns) - ddAC-THP (Paclitaxel) (trastuzumab-dkst) - ddAC-THP (Paclitaxel) (trastuzumab-dttb) - ddAC-THP (Paclitaxel) (trastuzumab-herw) - ddAC-THP (Paclitaxel) (trastuzumab-pkrb) - ddAC-THP (Paclitaxel) (trastuzumab-qyyp) - ddAC-THP (Paclitaxel) (trastuzumab-strf) - ddAC-THP (Paclitaxel) (trastuzumab-zerc)